INFI - Infinity Pharmaceuticals Inc. (INFI) CEO Adelene Perkins on Q2 2019 Results - Earnings Call Transcript
Infinity Pharmaceuticals, Inc. (INFI)
Q2 2019 Earnings Conference Call
July 30, 2019 08:00 AM ET
Company Participants
Jayne Kauffman - Senior Executive Coordinator
Adelene Perkins - CEO
Lawrence Bloch - President
Sam Agresta - Chief Medical Officer
Jeff Kutok - Chief Scientific Officer
Conference Call Participants
Matthew Bannon - J.P. Morgan
Kevin DeGeeter - Oppenheimer
Soumit Roy - JonesTrading
George Zavoico - B. Riley FBR
James Molloy - Alliance Global Partners
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the Company's Financial Results for